We are pleased to announce that Oncomatryx Biopharma will be attending BIO 2024 in San Diego from June 3-6. We look forward to connecting with biotech leaders and exploring

  From May 12-14 May Oncomatryx Biopharma will be attending BioEquity Europe 2024 in Donosti – San Sebastian We hope to meet you at BioEquity and make the most of

12 Annual PEGS Europe Virtual Summit 2020 9 Nov – 12 Nov 2020 Myriam Fabre, PhD. (Oncomatryx R&D Director) will attend the virtual conference as a speaker on next Tuesday

ESMO 2018 Congress Munich, Germany – 19 Oct – 23 Oct 2018 Myriam Fabre, PhD. (Oncomatryx R&D Director) presents the poster: OMTX705, a powerful stroma-targeting ADC to treat invasive tumors with

Oncomatryx will attend BIO EUROPE SPRING 2018, the essential appointment in biotechnology BIO EUROPE SPRING 2018 March 12-14, 2018 Amsterdam, The Netherlands https://ebdgroup.knect365.com/bioeurope- If you are also attending this event and you would like

Oncomatryx will attend BIO 2017, the Global Event for Biotechnology.  

ENTURE SUMMIT WEST 2017 February 28 – March 1 2017 Mountain View, CA USA David Raksin, our Business Development Director will be a Presenting role as a Top Innovator in

Oncomatryx will attend BIOEUROPE. November 7-9. Cologne. FOCUS. November 9-12. Cyprus.   If you are also attending any of these events and you would like to meet us please fill

Oncomatryx at the “Cancer Metabolism and the Tumour Microenvironment Conference”. 9-12, November. Paphos, Cyprus. Myriam Fabre, PhD. (Oncomatryx R&D Director) will attend the conference as speaker: TARGETING TUMOR MICROENVIRONMENT TO